Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports

Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ana Victoria Carro Martínez, Lydia Montolio Chiva, Montserrat Robustillo Villarino
Formato:	article
Lenguaje:	EN
Publicado:	BioExcel Publishing Ltd 2021
Materias:	disease-modifying anti-rheumatic drugs leukapheresis non-steroidal anti-inflammatory agents pain psoriatic arthritis rheumatoid arthritis tumour necrosis factor inhibitors Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/5dd821439fed490c98c8d37c331e38fa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5dd821439fed490c98c8d37c331e38fa
record_format	dspace
spelling	oai:doaj.org-article:5dd821439fed490c98c8d37c331e38fa2021-11-05T13:37:38ZGranulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports10.7573/dic.2021-8-51740-4398https://doaj.org/article/5dd821439fed490c98c8d37c331e38fa2021-11-01T00:00:00Zhttps://www.drugsincontext.com/granulocyte-and-monocyte-macrophage-apheresis-for-the-treatment-of-immune-mediated-inflammatory-arthropathies:-case-reportshttps://doaj.org/toc/1740-4398Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through a column with cellulose acetate beads to remove increased and activated myeloid lineage cells and improve the cytokine profile. The technique reduces pain and inflammation. We present four clinical reports that illustrate the clinical uses of GMA with the medical device Adacolumn® in patients with different backgrounds and immune-mediated inflammatory arthritis. The results were positive, and no adverse events were reported.Ana Victoria Carro Martínez Lydia Montolio ChivaMontserrat Robustillo VillarinoBioExcel Publishing Ltdarticledisease-modifying anti-rheumatic drugsleukapheresisnon-steroidal anti-inflammatory agentspainpsoriatic arthritisrheumatoid arthritistumour necrosis factor inhibitorsTherapeutics. PharmacologyRM1-950ENDrugs in Context, Vol 10, Pp 1-7 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	disease-modifying anti-rheumatic drugs leukapheresis non-steroidal anti-inflammatory agents pain psoriatic arthritis rheumatoid arthritis tumour necrosis factor inhibitors Therapeutics. Pharmacology RM1-950
spellingShingle	disease-modifying anti-rheumatic drugs leukapheresis non-steroidal anti-inflammatory agents pain psoriatic arthritis rheumatoid arthritis tumour necrosis factor inhibitors Therapeutics. Pharmacology RM1-950 Ana Victoria Carro Martínez Lydia Montolio Chiva Montserrat Robustillo Villarino Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
description	Drug therapy of immune-mediated inflammatory arthropathies is not always satisfactory, and there is a risk of adverse events. Granulocyte and monocyte/macrophage apheresis (GMA) is a non-pharmacological therapeutic option that is beneficial and very well tolerated. GMA involves passing blood through a column with cellulose acetate beads to remove increased and activated myeloid lineage cells and improve the cytokine profile. The technique reduces pain and inflammation. We present four clinical reports that illustrate the clinical uses of GMA with the medical device Adacolumn® in patients with different backgrounds and immune-mediated inflammatory arthritis. The results were positive, and no adverse events were reported.
format	article
author	Ana Victoria Carro Martínez Lydia Montolio Chiva Montserrat Robustillo Villarino
author_facet	Ana Victoria Carro Martínez Lydia Montolio Chiva Montserrat Robustillo Villarino
author_sort	Ana Victoria Carro Martínez
title	Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
title_short	Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
title_full	Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
title_fullStr	Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
title_full_unstemmed	Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
title_sort	granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports
publisher	BioExcel Publishing Ltd
publishDate	2021
url	https://doaj.org/article/5dd821439fed490c98c8d37c331e38fa
work_keys_str_mv	AT anavictoriacarromartinez granulocyteandmonocytemacrophageapheresisforthetreatmentofimmunemediatedinflammatoryarthropathiescasereports AT lydiamontoliochiva granulocyteandmonocytemacrophageapheresisforthetreatmentofimmunemediatedinflammatoryarthropathiescasereports AT montserratrobustillovillarino granulocyteandmonocytemacrophageapheresisforthetreatmentofimmunemediatedinflammatoryarthropathiescasereports
_version_	1718444230530039808

Granulocyte and monocyte/macrophage apheresis for the treatment of immune-mediated inflammatory arthropathies: case reports

Ejemplares similares